Menon, Entwistle, V., Campbell, A. V., & van Delden, J. J. M. (2021). How should the “privilege” in therapeutic privilege be conceived when considering the decision-making process for patients with borderline capacity? Journal of Medical Ethics, 47(1), 47–50. https://doi.org/10.1136/medethics-2019-105792
Sims, Nelson, K. J., & Sisti, D. (2021). Borderline personality disorder, therapeutic privilege, integrated care: is it ethical to withhold a psychiatric diagnosis? Journal of Medical Ethics, medethics–2021–107216–. https://doi.org/10.1136/medethics-2021-107216
Chan, Tulloch, E., Cooper, E. S., Smith, A., Wojcik, W., & Norman, J. E. (2017). Montgomery and informed consent: where are we now? BMJ, 357, j2224–j2224. https://doi.org/10.1136/bmj.j2224
Finnerty. (2021). The Privilege of Information-An Examination of the Defence of Therapeutic Privilege and its Implications for Pregnant Women. Medical Law Review, 29(4), 639–660. https://doi.org/10.1093/medlaw/fwab035
Mulheron. (2017). Has Montgomery Administered the Last Rites to Therapeutic Privilege? A Diagnosis and a Prognosis. Current Legal Problems, 70(1), 149–188. https://doi.org/10.1093/clp/cux002
Epstein, Korones, D. N., & Quill, T. E. (2010). Withholding Information from Patients — When Less Is More. The New England Journal of Medicine, 362(5), 380–381. https://doi.org/10.1056/NEJMp0911835
. Chan, Tulloch, E., Cooper, E. S., Smith, A., Wojcik, W., & Norman, J. E. (2017). Montgomery and informed consent: where are we now? BMJ, 357, j2224–j2224. https://doi.org/10.1136/bmj.j2224